@PFIZE®baba

 

bubu12 : ce que je sais par contre mais c’est qu’il est le seul pour le moment à tenir ce discours.

le sujet c’est la soit disant dangerosité de la protéine Spike

simplement la vous avez des gens qui affirment des choses sans le prouver.

En science quand vous êtes le seul à affirmer quelque chose sans pouvoir le prouver ca ne vaut rien c’est tout.

 

Avez-vous vécu dans une grotte ces derniers mois ???

 

Circulating SARS-CoV-2 Vaccine Antigen Detected in the Plasma of mRNA-1273 Vaccine Recipients

 Clinical Infectious Diseases, ciab465, https://doi.org/10.1093/cid/ciab465

 

The S1 protein of SARS-CoV-2 crosses the blood–brain barrier in mice

 Nature Neuroscience volume 24, pages 368–378 (2021)

 The novel coronavirus’ spike protein plays additional key role in illness

Salk researchers and collaborators show how the protein damages cells, confirming COVID-19 as a primarily vascular disease

 

The SARS-CoV-2 spike protein alters barrier function in 2D static and 3D microfluidic in-vitro models of the human blood–brain barrier

 SARS-CoV-2 Spike Proteins Disrupt the Blood-Brain Barrier, Potentially Raising Risk of Neurological Damage in COVID-19 Patients

October 29, 2020

 SARS-CoV-2 Spike Protein Elicits Cell Signaling in Human Host Cells : Implications for Possible Consequences of COVID-19 Vaccines

by Yuichiro J. Suzuki1,* [OrcID] and Sergiy G. Gychka

Vaccines 2021, 9(1), 36 ; https://doi.org/10.3390/vaccines9010036

 

SARS-CoV-2 binds platelet ACE2 to enhance thrombosis in COVID-19

 Journal of Hematology & Oncology volume 13, Article number : 120 (2020)

 Thrombosis after covid-19 vaccination

BMJ 2021 ; 373 doi : https://doi.org/10.1136/bmj.n958 (Published 14 April 2021)

 The SARS-CoV-2 spike protein disrupts the cooperative function of human cardiac pericytes - endothelial cells through CD147 receptor-mediated signalling : a potential non-infective mechanism of COVID-19 microvascular disease

Elisa Avolio, Monica Gamez, Kapil Gupta, Rebecca Foster, Imre Berger, Massimo Caputo, Andrew Davidson, Darryl Hill, Paolo Madeddu

doi : https://doi.org/10.1101/2020.12.21.423721

 SARS-CoV-2 Spike Protein and Lung Vascular Cells

by Sri Jayalakshmi Suresh and Yuichiro Justin Suzuki

J. Respir. 2021, 1(1), 40-48 ; https://doi.org/10.3390/jor1010004

 Complete protection by a single dose skin patch delivered SARS-CoV-2 spike vaccine

Authors : Christopher L.D. McMillan1,†, Jovin J.Y. Choo1,†, Adi Idris2, Aroon Supramaniam2,Naphak Modhiran1, Alberto A. Amarilla1, Ariel Isaacs1, Stacey T.M. Cheung1, Benjamin Liang1,Helle Bielefeldt-Ohmann1,4,5, Armira Azuar1, Dhruba Acharya2, Gabrielle 5 Kelly2, Germain J.P.Fernando1,3, Michael J. Landsberg1,4, Alexander A. Khromykh1,4, Daniel Watterson1,4, Paul R.Young1,4, Nigel A.J. McMillan2, David A. Muller1,*

 COVID-19 alters human genes, explaining mystery behind coronavirus ‘long haulers’

April 28, 2021

 “Vaccine-Induced Covid-19 Mimicry” Syndrome :

Splice reactions within the SARS-CoV-2 Spike open reading frame result in Spike protein variants that may cause thromboembolic events in patients immunized with vector-based vaccines

Eric Kowarz, Lea Krutzke, Jenny Reis, Silvia Bracharz, Stefan Kochanek, Rolf Marschalek

DOI :10.21203/rs.3.rs-558954/v1

 

SARS-CoV-2 Spike Protein Impairs Endothelial Function via Downregulation of ACE2

Yuyang Lei, Jiao Zhang, Cara R Schiavon, Ming He, Lili Chen, Hui Shen, Yichi Zhang, Qian Yin, Yoshitake Cho, Leonardo Andrade, Gerry S Shadel, Mark Hepokoski, Ting Lei, Hongliang Wang, Jin Zhang, Jason X-J Yuan, Atul Malhotra, Uri Manor, Shengpeng Wang, Zu-Yi Yuan, John Y-J Shyy

 PMID : 33300001 PMCID : PMC7724674 DOI : 10.1101/2020.12.04.409144